We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Selective Estrogen Modulation and Melatonin in Early COVID-19 (SENTINEL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04531748
Recruitment Status : Withdrawn (Funding)
First Posted : August 28, 2020
Last Update Posted : May 10, 2021
Information provided by (Responsible Party):
Reena Mehra, MD, The Cleveland Clinic

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : September 2022